Deutsche Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-62,031
| Closed | -$1.11M | – | 4550 |
|
|
2020
Q2 | $1.11M | Sell |
62,031
-973,542
| -94% | -$13.5M | ﹤0.01% | 2143 |
|
|
2020
Q1 | $7.38M | Buy |
1,035,573
+540,766
| +109% | +$6.75M | 0.01% | 1046 |
|
|
2019
Q4 | $11.8M | Buy |
494,807
+226,509
| +84% | +$6.25M | 0.01% | 1008 |
|
|
2019
Q3 | $7.19M | Sell |
268,298
-198,802
| -43% | -$5.58M | 0.01% | 1211 |
|
|
2019
Q2 | $12.7M | Buy |
467,100
+193,120
| +70% | +$6.06M | 0.01% | 1217 |
|
|
2019
Q1 | $9.51M | Buy |
273,980
+57,407
| +27% | +$1.66M | 0.01% | 1409 |
|
|
2018
Q4 | $4.23M | Sell |
216,573
-240,619
| -53% | -$4.95M | ﹤0.01% | 1887 |
|
|
2018
Q3 | $12.2M | Buy |
457,192
+200,981
| +78% | +$6.56M | 0.01% | 1491 |
|
|
2018
Q2 | $9.68M | Sell |
256,211
-448,417
| -64% | -$17.2M | ﹤0.01% | 1780 |
|
|
2018
Q1 | $23M | Buy |
704,628
+73,621
| +12% | +$3.23M | 0.01% | 1025 |
|
|
2017
Q4 | $30.7M | Buy |
631,007
+18,012
| +3% | +$911K | 0.02% | 748 |
|
|
2017
Q3 | $33.1M | Sell |
612,995
-13,803
| -2% | -$810K | 0.02% | 732 |
|
|
2017
Q2 | $35.2M | Buy |
626,798
+235,227
| +60% | +$9.42M | 0.03% | 671 |
|
|
2017
Q1 | $15.3M | Buy |
391,571
+50,788
| +15% | +$1.62M | 0.01% | 1017 |
|
|
2016
Q4 | $7.64M | Sell |
340,783
-135,711
| -28% | -$2.65M | 0.01% | 1419 |
|
|
2016
Q3 | $10.8M | Sell |
476,494
-69,140
| -13% | -$1.62M | 0.01% | 1263 |
|
|
2016
Q2 | $12.9M | Buy |
545,634
+36,547
| +7% | +$902K | 0.01% | 1157 |
|
|
2016
Q1 | $10.4M | Buy |
509,087
+190,332
| +60% | +$6.04M | 0.01% | 1243 |
|
|
2015
Q4 | $16.4M | Sell |
318,755
-38,406
| -11% | -$1.86M | 0.01% | 1023 |
|
|
2015
Q3 | $15.2M | Buy |
357,161
+60,423
| +20% | +$2.92M | 0.01% | 1042 |
|
|
2015
Q2 | $13.5M | Buy |
296,738
+77,773
| +36% | +$3.13M | 0.01% | 1156 |
|
|
2015
Q1 | $8.31M | Buy |
218,965
+58,796
| +37% | +$2.02M | 0.01% | 1457 |
|
|
2014
Q4 | $4.54M | Sell |
160,169
-30,121
| -16% | -$837K | ﹤0.01% | 2034 |
|
|
2014
Q3 | $4.81M | Buy |
190,290
+155,367
| +445% | +$4.09M | ﹤0.01% | 1867 |
|
|
2014
Q2 | $1.02M | Buy |
34,923
+3,649
| +12% | +$88.3K | ﹤0.01% | 2931 |
|
|
2014
Q1 | $809K | Buy |
31,274
+1,922
| +7% | +$51.3K | ﹤0.01% | 3012 |
|
|
2013
Q4 | $754K | Buy |
29,352
+3,415
| +13% | +$83K | ﹤0.01% | 2821 |
|
|
2013
Q3 | $693K | Buy |
25,937
+7,695
| +42% | +$183K | ﹤0.01% | 3248 |
|
|
2013
Q2 | $447K | Buy |
+18,242
| New | +$363K | ﹤0.01% | 3244 |
|
Deutsche Bank's PTLA Position: Q3 2020 in Review
Deutsche Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 62,031 shares — an estimated $1.11M sold.
Deutsche Bank first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $35.2M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Deutsche Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Deutsche Bank sold 62,031 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.11M.
- Deutsche Bank first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- Deutsche Bank's Portola Pharmaceuticals, Inc. position peaked at $35.2M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Deutsche Bank's 13F filing for Q3 2020, filed 12 Nov 2020.